These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7159921)

  • 1. Ergotamine abuse: results of ergotamine discontinuation, with special reference to the plasma concentrations.
    Ala-Hurula V; Myllylä V; Hokkanen E
    Cephalalgia; 1982 Dec; 2(4):189-95. PubMed ID: 7159921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcranial Doppler ultrasonographic features during drug withdrawal from drug-induced headache. A transcranial Doppler follow-up study.
    Haase CG; Diener HC
    Headache; 1998 Oct; 38(9):679-83. PubMed ID: 15613180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Headache caused by analgesic and/or ergotamine abuse].
    Panconesi A; Del Bianco PL; Curradi C; Franchi G; Anselmi B; Andreini R
    Clin Ter; 1991 May; 137(3):169-83. PubMed ID: 1831085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year follow-up.
    Schnider P; Aull S; Baumgartner C; Marterer A; Wöber C; Zeiler K; Wessely P
    Cephalalgia; 1996 Nov; 16(7):481-5; discussion 461. PubMed ID: 8933992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of ergotamine-induced headache and ergotamine withdrawal on information processing.
    Evers S; Schmidt F; Bauer B; Voss H; Grotemeyer KH; Husstedt IW
    Psychopharmacology (Berl); 1999 Feb; 142(1):61-7. PubMed ID: 10102783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs.
    Hering R; Steiner TJ
    Lancet; 1991 Jun; 337(8755):1442-3. PubMed ID: 1675320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ergotamine abuse. Do patients benefit from withdrawal?
    Tfelt-Hansen P; Krabbe A
    Cephalalgia; 1981 Mar; 1(1):29-32. PubMed ID: 15645831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ergotamine tartrate dependency: features and possible mechanisms.
    Saper JR; Jones JM
    Clin Neuropharmacol; 1986; 9(3):244-56. PubMed ID: 3087616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ['Only ergotamine still helps'].
    Ferrari MD; Mulder LJ
    Ned Tijdschr Geneeskd; 1991 Jul; 135(27):1209-11. PubMed ID: 1861750
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation between pharmacokinetics and clinical effects of ergotamine in patients suffering from migraine.
    Ala-Hurula V
    Eur J Clin Pharmacol; 1982; 21(5):397-402. PubMed ID: 7075645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular adaptation in migraineurs with chronic daily headache.
    Hering R; Gardiner I; Catarci T; Whitmarsh T; Steiner T; de Belleroche J
    Cephalalgia; 1993 Aug; 13(4):261-6. PubMed ID: 8397071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter: Ergotamine-induced headaches.
    Wainscott G; Volans G; Wilkinson M
    Br Med J; 1974 Jun; 2(5921):724. PubMed ID: 4852779
    [No Abstract]   [Full Text] [Related]  

  • 13. Low biological availability of ergotamine tartrate after oral dosing in cluster headache.
    Ekbom K; Paalzow L; Waldenlind E
    Cephalalgia; 1981 Dec; 1(4):203-7. PubMed ID: 6812961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of ergotamine abuse on psychological and cognitive functioning.
    Roon KI; Bakker D; van Poelgeest MI; van Buchem MA; Ferrari MD; Middelkoop HA
    Cephalalgia; 2000 Jun; 20(5):462-9. PubMed ID: 11037742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ergotamine toxicity and serum concentrations of ergotamine in migraine patients.
    Graham AN; Johnson ES; Persaud NP; Turner P; Wilkinson M
    Hum Toxicol; 1984 Jun; 3(3):193-9. PubMed ID: 6430784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use and abuse of analgesics in tension-type headache.
    Schnider P; Aull S; Feucht M; Mraz M; Travniczek A; Zeiler K; Wessely P
    Cephalalgia; 1994 Apr; 14(2):162-7. PubMed ID: 8062356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of ergotamine withdrawal symptoms with naproxen.
    Mathew NT
    Headache; 1987 Mar; 27(3):130-3. PubMed ID: 3298163
    [No Abstract]   [Full Text] [Related]  

  • 18. Longterm prognosis of analgesic withdrawal in patients with drug-induced headaches.
    Baumgartner C; Wessely P; Bingöl C; Maly J; Holzner F
    Headache; 1989 Sep; 29(8):510-4. PubMed ID: 2793455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Headache caused by a sphenoid mucocele but presenting as an ergotamine-induced headache.
    Bauer B; Evers S; Lindörfer HW; Schuierer G; Henningsen H; Husstedt IW
    Headache; 1997; 37(7):460-2. PubMed ID: 9277033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Daily chronic headache in patients with migraine induced by abuse of ergotamine-analgesics: response due to a protocol of outpatient treatment].
    Pascual J; Berciano J
    Neurologia; 1993; 8(7):212-5. PubMed ID: 8104438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.